Skip to main navigation Skip to search Skip to main content

Low doses amino-bisphosphonates stimulate keratinocytes growth inactivating glucocorticoid receptor

Research output: Contribution to journalArticlepeer-review

Abstract

Amino-bisphosphonates (N-BPs) have a wide range of clinical applications to treat bone diseases. Their activity lowered farnesyl pyrophosphate (FPP) endogenous levels by inhibiting FPP synthase. In epithelial cells it has been demonstrated that FPP reduces both cell proliferation and migration activting glucocorticoid receptor. In this study two N-BPs (zoledronate and neridronate) used at low concentrations (100 nM to 10 μM) are able to stimulate human keratinocytes proliferation reducing glucocorticoid receptor activation.

Original languageEnglish
Pages (from-to)301-304
Number of pages4
JournalEuropean Journal of Pharmacology
Volume721
Issue number1-3
DOIs
Publication statusPublished - 5 Dec 2013

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Keywords

  • Amino-bisphosphonate
  • Glucocorticoid receptor
  • Human keratinocyte

Fingerprint

Dive into the research topics of 'Low doses amino-bisphosphonates stimulate keratinocytes growth inactivating glucocorticoid receptor'. Together they form a unique fingerprint.

Cite this